SARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY

Similar documents
POLICY STATEMENT: Critical values as defined below, shall be communicated in accordance with the following guidelines.

Affiliated Laboratory, Inc. General Lab Policy Manual. Clinical Laboratory Critical Result Notification

TITLE CLIN_189 CRITICAL RESULT NOTIFICATION. APPLICABILITY Edward Hospital, Linden Oaks Hospital

Impact of the critical limits to improve the patient health care. Dr. Rubina Mansoor Assistant Professor Rawalpindi Medical College, Rawalpindi.

West Chester Hospital Patient Price Information List

SARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY

University of Cincinnati Medical Center Patient Price Information List

Patient Price Information List

SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY

We appreciate your help in reminding members to also open any mail from TennCare and follow the directions.

SARASOTA MEMORIAL HOSPITAL POLICY

Patient Price Information List

Session Number 208 LAB POTPOURRI WHAT EVERY CRITICAL CARE NURSE NEEDS TO KNOW ABOUT COMMON LABS

Room and Board -- Per Day Charges

SARASOTA MEMORIAL HOSPITAL POLICY

HealthEast Medical Laboratory

Abstract. Clinical Chemistry / Critical Value Reporting by Text Message

Long-Term Care / Assisted Living. 45 West 10 th Street St. Paul, MN Telephone: Fax:

PURPOSE: This policy provides an overview of SHANDS Jacksonville Laboratory s commitment to the care and safety of the patients we serve.

Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN

SARASOTA MEMORIAL HOSPITAL POLICY

What You Need to Know

PART I HAWAII HEALTH SYSTEMS CORPORATION STATE OF HAWAII Class Specification for the

SARATOGA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE SERVICE DIRECTORY

Charting the Future: Implications and Insights for Informatics. Dana Alexander RN MSN MBA FHIMSS FAAN

Laboratory Services Policy, Professional

Directory of Laboratory Services th edition

TITLE: Processing Provider Orders: Inpatient and Outpatient

How to Improve the Laboratory Experience CLS and MLT Working Together

SARASOTA MEMORIAL HOSPITAL POLICY

Laboratory Services Policy

Overview: Scope of Work: RFP Requirements: RFP for EHR Data Collection Center

OUTPATIENT ENDOSCOPY (PULM) PROCEDURE PLAN - Phase: Diagnostic/Pre-Op Orders

NCLEX ALTERNATIVE FORMAT ITEMS

Sepsis Screening Tools

TRAVELLERS WELCOME TO TORONTO, ONTARIO, CANADA

TRAVELLERS WELCOME TO TORONTO, ONTARIO, CANADA

THE VALUE OF CAP S Q-PROBES & Q-TRACKS

Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2

Patient Price Information List

A university wishing to have an accredited program in adult Infectious Diseases must also sponsor an accredited program in Internal Medicine.

Request for Proposals: Laboratory External Quality Assessment (EQA) Proficiency Testing Program in Kenya

Measuring Medication Harm: Advantages of Using a Trigger Tool. Frank Federico Executive Director

American Society of ExtraCorporeal Technology. Standards and Guidelines. for Mechanical Circulatory Support

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST

Fulton County Medical Center. Position Description. Pathologist, Laboratory Manager, and Medical Technologist

Saves counter space and money while improving in-house testing capability

Room and Board -- Per Day Charges. Labor and Delivery Charges. Emergency Department Charges

DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK

SARASOTA MEMORIAL HOSPITAL PERIOPERATIVE DEPARTMENT POLICY

Patient Price Information List

Investigating Clostridium difficile Infections

ORIGINAL SIGNED BY DR. PETERS Mark J. Peters, M.D., President and CEO

Respirator. Prerequisit. te: RSPT Co-requisit. cies ) care. having. 4. Apply. interviews

Patient Price Information List

Viral Load Scale-Up Clinical Facility Readiness Assessment

C. difficile Infection and C. difficile Lab ID Reporting in NHSN

Title: Reporting Critical Values Site(s): DSM. Document #: Version #: 03. Section: Operations Subsection: General Laboratory

Section: Hematology Subsection: Miscellaneous. Approved by: Dr. Carmen Morales Written By: Hematology Discipline Signature:

ACCOUNT NO. MED. REC. NO. NAME BIRTHDATE ALL ORDERS MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE.

STANDARDIZED PROCEDURE HEPATIC ARTERY INFUSION OF CHEMOTHERAPY (Adults, Peds)

CAH PREPARATION ON-SITE VISIT

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Annual Compliance Notice to Providers 2013

SARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE MATERNAL TRANSPORT TEAM


Internal Medicine Curriculum Infectious Diseases Rotation

Current Status: Active PolicyStat ID: Guideline: Sepsis Identification And Management in Adults GUIDELINE: COPY

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY

SARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE CARDIAC ACUTE CARE AND CARDIAC PROGRESSIVE UNITS

Sepsis Screening & Code Sepsis in Critical Care Units (Medical, Surgical, & CCU)

Basic Skills for CAH Quality Managers

Infection Prevention and Control

Avenue Healthcare REVISED Outpatient Consultation Charges effective 1 st June 2017

AIMS FELLOWSHIP CURRICULUM HAEMATOLOGY II

Global Health Electives Curriculum Overview Internal Medicine Residency University of Colorado Health Sciences Center January 2007

Clinic al Pathway: Ventricular Septal Defect (VSD) Repair

Phlebotomy: Service Guide Policy

ACCOUNT NO. MED. REC. NO. NAME BIRTHDATE. Patient Identification ALL ORDERS MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE.

APPLICATION. Thank you for your interest in applying for the APIC Program of Distinction.

CRAIG HOSPITAL POLICY/PROCEDURE

AI Powered Early Warning System to Improve Patient Safety

SARASOTA MEMORIAL HOSPITAL

Investigation Outline for a Reportable Incident Non-Hospital Surgical Facility

S T A N D A R D O P E R A T I N G G U I D E L I N E

Activation of the Rapid Response Team

MEASURE DHS SERVICE PROVISION ASSESSMENT SURVEY HEALTH WORKER INTERVIEW

Aldijana Avdić, BSN, RN, PBMS, CPHQ Assistant Director, Patient Safety and Privacy 1

Using Electronic Health Records for Antibiotic Stewardship

SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY

College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program. Policy Manual Edition

MEDICATION TEST NAME: TITLE: SIGNATURE: DATE: 1. In extreme cases of salicylate poisoning, which of the following treatments is used?

POLICIES. Billing. ABN (Advance Beneficiary Notice)

CLINICAL CHEMISTRY. Phone: The department is staffed 24 hours a day.

CHAPTER 13 SECTION 3.4 LABORATORY SERVICES

Piedmont Access to Health Services. Standing Orders for Patient Work-ups

2016 Kentucky Rural Health Clinic Summit. Kate Hill, RN VP Clinical Services

Patient Safety (PS) 1) A collaborative process is used to develop policies and/or procedures that address the accuracy of patient identification.

Fiscal Year 2017 (10/01/16-9/30/17) ESRD CORE SURVEY DATA WORKSHEET

Global Outreach Activity Menu

Transcription:

TITLE: SARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY REPORTING OF CRITICAL RESULTS AND DIAGNOSTIC PROCEDURES POLICY #: EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY TYPE: 02/20/06 3/30/18 Clinical 1 of 7 Job Title of Responsible Owner: Director of Critical Care, Trauma Services, and Hemodialysis S1013 Non-Clinical PURPOSE: POLICY STATEMENT: To identify the process for reporting critical results of tests and diagnostic procedures on a timely basis to the responsible licensed caregiver so the patient can be promptly treated. Each department performing tests should define, the timeframe for reporting, and who will report, to a licensed caregiver EXCEPTIONS: A physician may elect not to be called in the event a critical result is expected and has provided orders to address the result. PROCEDURE: 1. The ancillary personnel or MD/DO of the testing department will notify the ordering/designated physician or the licensed nurse caring for the patient. At the time the result is provided and the result is in the electronic medical record (EMR), there will be a verbal read back from the person receiving the result to the person reporting the result. If the critical result is not in the EMR, the person receiving the result will write down and read back the written information to the reporting person to ensure accuracy of the communication. 2. If the testing department does not notify the ordering physician, the values will be called to a licensed nurse, a verbal read back will be completed and the nurse will within one hour of the resulted test: a. inform the physician or his designee of the result, including a verbal read back, or b. implement any previously received orders regarding test results, or c. implement an approved protocol. 3. The qualified personnel shall document any physician(s) or designee notified of the results. a. In SCM, in any and/or other electronic system, physician notification, under the assessment/reassessment flow sheet; b. Other designated area in paper chart.

2 of 9 4. Unavailability of responsible licensed caregiver when the responsible licensed caregiver is not available, follow policy 01.ADM.00 Chain of Command. 5. Any critical tests results will be communicated by the interpreting physician or technologist to the ordering/covering physician or to the licensed nurse caring for the patient if the physician is not available. 6. Critical results obtained after the patient is discharged will be called to the ordering physician or designee per protocol. RESPONSIBILITY: It is the responsibility of the department directors to see that the staff is aware of, and adhere to, this policy. It will be the physician's responsibility to notify the patient of the results. REFERENCES: The JC Comprehensive Accreditation Manual for Hospitals (CAMH) Joint Commission, NPSG 02.03.01. Lab Policy 119.020, Lab, Result Notification Values Critical Results SMH Policy Chain of Command (01.ADM.00). SMH: Author. AUTHOR(S): ATTACHMENT(S): Dana Rickard, Laboratory Mark Pellman, Director, Respiratory Care Services Sue Olsen, Director of Critical Care, Trauma, Hemodialysis Mary Geary, Executive Director, Quality Reporting of Results by Department APPROVALS:

3 of 9 Signatures indicate approval of the new or reviewed/revised policy. Committees/Sections/Departments: Date Quality Improvement/Patient Safety Committee Mary Geary, PhD, RN 3/27/2018 Director/Responsible Owner: Vice President/Executive Director: Chief of Medical Operations: (if clinical policy or appropriate) Chief of Staff: (if clinical policy or appropriate) Sue Olsen, MSN, RN, CCRN, CNML Director of Critical Care 3/14/2018 Connie Andersen, RN, CNO 3/15/2018 Dr. James Fiorica, MD, CMO 3/21/2018 Medical Executive Committee: (if clinical and review requested by CMO and COS) Chief Executive Officer (Interim): David Verinder, CEO 3/23/2018

4 of 9 Department Description of Test Reported Reporting Flow Critical Results per Department Respiratory Care Laboratory Blood Gas High and Low Critical Results, policy BLG.001 *unless excluded by physician order High or low critical lab results as notified by lab. See attached addendum. Respiratory Therapist to licensed nurse or physician Medical Technologist or Technician to attending nurse or covering physician PaO2 less than 60 or greater than 125 PaCO2 less than 25 or greater than 50 ph less than 7.30 or greater than 7.55 Exceptions: 1. Patients on O2 therapy that are being taken off for room air ABG s only. 2. Patients with chronic PaC02 >50 with a ph of 7.35-7.45 3. Patients with chronic Pa02 < 60 with Sa02> 92%. Patients with Pa02 > 125 with order or a 02 protocol.

5 of 9 PHYSICIAN NOTIFICATION CRITICAL RESULT LIST TEST NAME UNITS PANIC RESULT LOWER UPPER Acetaminophen ug/ml >150 Acid Fast Culture Acid Fast, Smear Alcohol, Ethyl gm/dl >.350 Amikacin ug/ml Trough: >10.0 Peak: >35.0 Aminophylline ug/ml >20 Ammonia Adult umol/l >75 Child <10y umol/l >39 Bilirubin, Neonatal 0-2 Months mg/dl >15 Bilirubin, Total 0-6 Days mg/dl >15 Blood Count-parts thereof Path review ordered for 1 st occurrence inpatient Body Fluid-sterile site for clin. sig. pathogenic bacteria Blood Culture Bordetella pertussis * Calcium mg/dl <6.0 >14.0 Campylobacter * Carbon Dioxide (CO2) meq/l <12 >40 Chloride, Serum meq/l <70 >130 Clostridium Perfringens from wound Any isolated * Clostridium Difficile (OP notified in a.m. Cryptococcal Antigen Test CSF Culture CSF Gram Stain CSF Lactic Acid meq/l >3.2 CSF Smear CSF WBC /mm3 >9 Dialysis Water >200 CFU * Digoxin ug/ml >3.0 Dilantin ug/ml >30 Toxic: >40 Diphtheria on initial culture Diphtheria (not initial culture) * Direct Viral Stains E.Coli 0157:H7 (screen) * TEST NAME UNITS PANIC RESULT LOWER UPPER Fibrinogen mg/dl <100 Fibrinogen Degradation ug/ml >160 Products

6 of 9 FTA Fungus (systemic isolate) * Gentamicin ug/ml >2.5 trough >9.9 Peak Glucose Adult mg/dl <50 >400 Newborn 0-2M mg/dl <40 >300 Gram Stain, Blood Hematocrit Adult % <18 >60 Newborn 0-6D % <24 >70 CAN % <18 >60 Hemoglobin Adult gm/dl <6.0 >20.0 Newborn 0-6D gm/dl <8.0 >25.0 CAN gm/dl <6.0 >20.0 Heparin, Anti-Xa IU/ml >1.8 Hepatitis A IgM * Hepatitis B (Surface Antigen and Core IgM) HIV Influenza A&B Antigen Influenza A&B Antigen < 5 y * Iron, Total ug/dl >499 Kleihauers-Betke (fetal HGB stain) Lactic Acid, Blood meq/l >3.2 Legionella Urine Antigen *Lithium meq/l >2.0 Listeria monocytogenes * Malaria Smear Presumptive Magnesium mg/dl <1.1 >7.0 Methotrexate mcm/l >5.0 24 hrs past last dose N. meningitides * Partial Thromboplastin (APTT) sec. >125 >150 Pertussis * Phenobarbital ug/ml >60 Platelet /mm3 <50,000 >1,000,000 CAN /mm3 <10,000 >1,000,000 Potassium Adult meq/l <2.5 >6.2 Newborn 0-2M meq/l <2.7 >7.0 Prothrombin sec >44 (sec.may change with reagent sensitivity) INR >4.0 Salicylate mg/dl >30 Lethal: >60 Salmonella * Shigella *

7 of 9 Sodium meq/l <120 >155 Staphylococcus (VISA, VRSA) * Tegretol ug/ml >20 Tobramycin ug/ml Trough: >2.5 Peak: >10 Troponin >0.05 CT Urinalysis Newborn Ketone Trace or > Newborn Glucose Trace or > Vancomycin ug/ml Trough >20 Peak: >55 Vibrio * Viral Culture: 0-6 months of age Volatiles Acetone >250 mg/dl Methanol >40 mg/dl Isopropanol >150 mg/dl WBC Adult /mm3 <2,000 >30,000 Newborn /mm3 <2,500 >40,000 CAN /mm3 <2,000 >30,000 Western Blot Confirmed or indeterminant *denotes tests that lab reports immediately to infection control. Infection control contact information: Mon-Fri 6a.m. to 3p.m. Ext 1745. Afterhours and weekends the lab will call The County Health Dept. 941-861-2873